M. Humbert, C. Guignabert, S. Bonnet, P. Dorfmuller, J. R. Klinger et al., Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives, Eur Respir J, vol.53, 2019.

G. Simonneau, D. Montani, D. S. Celermajer, C. P. Denton, M. A. Gatzoulis et al., Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, 2019.

N. Galie, M. Humbert, J. L. Vachiery, S. Gibbs, I. Lang et al.,

. Esc/ers, Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Respir J, vol.46, pp.903-975, 2015.

L. Savale, L. Pavec, J. Mercier, O. Mussot, S. Jais et al., Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension, Ann Thorac Surg, vol.104, pp.404-411, 2017.

C. Guignabert, L. Tu, B. Girerd, R. N. Huertas, A. Montani et al., New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication, Chest, vol.147, pp.529-537, 2015.

A. Huertas, L. Tu, and C. Guignabert, New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways, Curr Opin Pulm Med, vol.23, pp.377-385, 2017.

S. Eddahibi, C. Guignabert, A. M. Barlier-mur, L. Dewachter, E. Fadel et al., Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia, Circulation, vol.113, pp.1857-1864, 2006.

L. Tu, F. S. De-man, B. Girerd, A. Huertas, M. C. Chaumais et al., A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents, Am J Respir Crit Care Med, vol.186, pp.666-676, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00905191

L. Tu, L. Dewachter, B. Gore, E. Fadel, P. Dartevelle et al., Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension, Am J Respir Cell Mol Biol, vol.45, pp.311-322, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00579959

L. Hiress, M. Tu, L. , R. N. Phan, C. Thuillet et al., Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex, Am J Respir Crit Care Med, vol.192, pp.983-997, 2015.

A. Huertas, L. Tu, R. Thuillet, L. Hiress, M. Phan et al., Leptin signalling system as a target for pulmonary arterial hypertension therapy, Eur Respir J, vol.45, pp.1066-1080, 2015.

Y. Tamura, C. Phan, L. Tu, L. Hiress, M. Thuillet et al., Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension, J Clin Invest, vol.128, pp.1956-1970, 2018.

N. Ricard, L. Tu, L. Hiress, M. Huertas, A. Phan et al., Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth musclelike cells in pulmonary hypertension, Circulation, vol.129, pp.1586-1597, 2014.

L. Hiress, M. Akagah, B. Bernadat, G. Tu, L. Thuillet et al., Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension, J Med Chem, vol.61, pp.2725-2736, 2018.

C. Guignabert, C. M. Alvira, T. P. Alastalo, H. Sawada, G. Hansmann et al., Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization, Am J Physiol Lung Cell Mol Physiol, vol.297, pp.1082-1090, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00499633

C. Guignabert, S. Bailly, and M. Humbert, Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations, Expert Opin Ther Targets, vol.21, pp.181-190, 2017.

L. Tu, A. Desroches-castan, C. Mallet, L. Guyon, A. Cumont et al., Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension, Circ Res, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02007505

F. Dierick, T. Hery, B. Hoareau-coudert, N. Mougenot, V. Monceau et al., Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension, Circ Res, vol.118, pp.822-833, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01304194

A. Q. Sheikh, A. Misra, I. O. Rosas, R. H. Adams, and D. M. Greif, Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension, Sci Transl Med, vol.7, pp.308-159, 2015.

A. Q. Sheikh, F. Z. Saddouk, A. Ntokou, R. Mazurek, and D. M. Greif, Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension, Cell Rep, vol.23, pp.1152-1165, 2018.

K. Yuan, E. A. Shamskhou, M. E. Orcholski, A. Nathan, S. Reddy et al., Loss of Endothelial Derived WNT5A is Associated with Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension, Circulation, 2018.

K. Yuan, N. Y. Shao, J. K. Hennigs, M. Discipulo, M. E. Orcholski et al., Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension, Am J Pathol, vol.186, pp.2500-2514, 2016.

J. Bordenave, R. Thuillet, L. Tu, C. Phan, G. Simonneau et al., Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model, Eur Respir J, vol.50, p.2385, 2017.

A. Huertas, F. Perros, L. Tu, S. Cohen-kaminsky, D. Montani et al., Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay, Circulation, vol.129, pp.1332-1340, 2014.